UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052741
Receipt number R000060123
Scientific Title Confirmation of the effect of hydration in the body through the ingestion of research foods -A randomized, placebo controlled, single blind, three-period crossover comparative trial-
Date of disclosure of the study information 2023/11/12
Last modified on 2023/12/25 15:08:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Confirmation of the effect of hydration in the body through the ingestion of research foods

Acronym

Confirmation of the effect of hydration in the body through the ingestion of research foods

Scientific Title

Confirmation of the effect of hydration in the body through the ingestion of research foods
-A randomized, placebo controlled, single blind, three-period crossover comparative trial-

Scientific Title:Acronym

Confirmation of the effect of hydration in the body through the ingestion of research foods
-A randomized, placebo controlled, single blind, three-period crossover comparative trial-

Region

Japan


Condition

Condition

Healthy male adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the effect of a single intake of a food ingredient on the rehydration of the body in males between the ages of 20 and 65.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Osmolality (serum, urine)

Key secondary outcomes

Blood tests, Urine tests, Urine volume, Body weight, body water balance, body temperature, blood pressure, pulse


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Test food 1, equal to the same amount of body weight loss after sauna, is ingested once.

Interventions/Control_2

Test food 2, equal to the same amount of body weight loss after sauna, is ingested once.

Interventions/Control_3

Placebo food, equal to the same amount of body weight loss after sauna, is ingested once.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male

Key inclusion criteria

(1)Male subjects ranging in age from 20 to 65 at informed consent.
(2)Subjects ranging in BMI from 18.5 to less than 25.0 kg/m2.
(3)Subjects who can visit the designated facility on measurement days.
(4)Subjects who can use smartphones or PC to record a digital diary.
(5)Subjects who can make self-judgment and voluntarily gave written informed consent.

Key exclusion criteria

(1) with irregular life rhythm (e.g., irregular shift work).
(2) Heavily drinkers (40 g or more as pure alcohol).
(3) Subjects having a habit of smoking.
(4) Persons who regularly consume health foods or supplements such as foods for specified health uses or foods with functional claims that may affect the study, and cannot stop taking them after consent is obtained
(5) Subjects with a systolic blood pressure of less than 90 mmHg.
(6) Subjects who donated their blood components and/or whole blood (over 0.2 L) within the past 4 weeks.
(7) Subjects who donated their whole blood (over 0.4 L) within the past 12 weeks.
(8) Subjects being collected in total of their blood (over 1.2 L) within the past 12 months and in this research.
(9) Subjects being under other clinical tests, or participated in those within the past four weeks, or will join those after the consent.
(10) Subjects who meet any of the following:
(a) suffering from heart, liver, or kidney disease (including complications of other diseases)
(b) having a history of cardiovascular disease
(c) diabetes
(d) allergic to the test foods and/or required one.
(11) Persons who have difficulty collecting blood
(12) Those who have difficulty sweating in the sauna
(13) Persons who are unable to take a sauna bath for 10 minutes x 3 times
(14) People who do not like closed spaces and cannot enter a solo sauna
(15) Persons with extensive burn scars
(16) Persons with tattoos
(17) Those who are judged by the study director or study sub-physician to be unsuitable as study subjects.

Target sample size

18


Research contact person

Name of lead principal investigator

1st name Hisako
Middle name
Last name Minami

Organization

Suntory beverage & Food limited.

Division name

Development & Designed Department

Zip code

2110067

Address

13-2 Imaikami-cho, Nakahara-ku, Kawasaki, Kanagawa, JAPAN

TEL

050-3182-6161

Email

Hisako_Nakamura@suntory.co.jp


Public contact

Name of contact person

1st name Kaori
Middle name
Last name Matsuoka

Organization

Suntory beverage & Food limited.

Division name

Development & Designed Department

Zip code

2110067

Address

13-2 Imaikami-cho, Nakahara-ku, Kawasaki, Kanagawa, JAPAN

TEL

05031820550

Homepage URL


Email

Kaori_Matsuoka@suntory.co.jp


Sponsor or person

Institute

IMEQRD Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Suntory beverage & Food limited.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Suda Clinic institutional review board

Address

2-8-14,Takadanobaba,Shinjyuku,Tokyo

Tel

03-6704-5968

Email

n-yuzawa@imeqrd.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団 成守会 はせがわ病院(東京都)


Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 10 Month 18 Day

Date of IRB

2023 Year 10 Month 17 Day

Anticipated trial start date

2023 Year 11 Month 13 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 11 Month 09 Day

Last modified on

2023 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060123


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name